PT  - JOURNAL ARTICLE
AU  - Yingxiang Huang
AU  - Dina Radenkovic
AU  - Kevin Perez
AU  - Kari Nadeau
AU  - Eric Verdin
AU  - David Furman
TI  - Age-dependent and Independent Symptoms and Comorbidities Predictive of COVID-19 Hospitalization
AID  - 10.1101/2020.08.14.20170365
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.08.14.20170365
4099  - http://medrxiv.org/content/early/2020/08/16/2020.08.14.20170365.short
4100  - http://medrxiv.org/content/early/2020/08/16/2020.08.14.20170365.full
AB  - The coronavirus disease 2019 (COVID-19) pandemic, caused by Severe Acute Respiratory Syndrome (SARS)-CoV-2, continues to burden medical institutions around the world by increasing total hospitalization and Intensive Care Unit (ICU) admissions1–9 A better understanding of symptoms, comorbidities and medication used for preexisting conditions in patients with COVID-19 could help healthcare workers identify patients at increased risk of developing more severe disease10,11. Here, we have used self-reported data (symptoms, medications and comorbidities) from more than 3 million users from the COVID-19 Symptom Tracker app12 to identify previously reported and novel features predictive of patients being admitted in a hospital setting. Despite previously reported association between age and more severe disease phenotypes13–18, we found that patient’s age, sex and ethnic group were minimally predictive when compared to patient’s symptoms and comorbidities. The most important variables selected by our predictive algorithm were fever, the use of immunosuppressant medication, mobility aid, shortness of breath and fatigue. It is anticipated that early administration of preventative measures in COVID-19 positive patients (COVID+) who exhibit a high risk of hospitalization signature may prevent severe disease progression.Competing Interest StatementThe authors have declared no competing interest.Funding Statementno external funding was receivedAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The study was approved under expedited review due to national pandemic response. It passed SAIL/Health Data Research UK - Information Governance Review Panel (IGRP) IGRP application form for project 1088 - COVID-19 Symptom Tracker - GSST - NHSAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData can be requested for access through The Health Data Research Hub for Respiratory Health, in partnership with SAIL Databank.